Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 792

1.

Multiple Placental Infarcts in a Pregnant Woman with Essential Thrombocythemia: A Case Report.

Edahiro Y, Ando J, Suzuki T, Fukumura Y, Masuda A, Sakayori S, Takeda J, Maruyama Y, Makino S, Itakura A, Komatsu N.

Intern Med. 2018 Aug 10. doi: 10.2169/internalmedicine.1311-18. [Epub ahead of print]

PMID:
30101937
2.

[iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas].

Ando M, Nakauchi H, Komatsu N.

Rinsho Ketsueki. 2018;59(7):932-938. doi: 10.11406/rinketsu.59.932. Japanese.

PMID:
30078805
3.

[Recurrent amylase-producing multiple myeloma responding to pomalidomide and carfilzomib-containing therapies].

Aota Y, Gotoh A, Okuda Y, Honda T, Watanabe N, Ando J, Komatsu N.

Rinsho Ketsueki. 2018;59(7):865-871. doi: 10.11406/rinketsu.59.865. Japanese.

PMID:
30078795
4.

Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.

Li TF, Li K, Zhang Q, Wang C, Yue Y, Chen Z, Yuan SJ, Liu X, Wen Y, Han M, Komatsu N, Xu YH, Zhao L, Chen X.

Biomaterials. 2018 Jul 26;181:35-52. doi: 10.1016/j.biomaterials.2018.07.035. [Epub ahead of print]

PMID:
30071380
5.

Correction to "Direct Fabrication of the Graphene-Based Composite for Cancer Phototherapy through Graphite Exfoliation with a Photosensitizer".

Liu G, Qin H, Amano T, Murakami T, Komatsu N.

ACS Appl Mater Interfaces. 2018 Aug 8;10(31):26813. doi: 10.1021/acsami.8b11270. Epub 2018 Jul 26. No abstract available.

PMID:
30048105
6.

Immune-bone interplay in the structural damage in rheumatoid arthritis.

Komatsu N, Takayanagi H.

Clin Exp Immunol. 2018 Jul 19. doi: 10.1111/cei.13188. [Epub ahead of print] Review.

PMID:
30022480
7.

Pleural effusion at diagnosis predicts extremely poor outcomes in patients with diffuse large B-cell lymphoma harbouring MYC rearrangement.

Nitta H, Gotoh A, Tanaka M, Sekiguchi Y, Ota Y, Noguchi M, Komatsu N.

Br J Haematol. 2018 Jul 5. doi: 10.1111/bjh.15431. [Epub ahead of print] No abstract available.

PMID:
29974930
8.

[A novel quantitative JAK2V617F detection kit: prospective clinical performance study comparing MPN patients and healthy subjects].

Kirito K, Koike M, Noguchi M, Kizaki M, Katayama N, Sugimoto Y, Dobashi N, Usui N, Komatsu N.

Rinsho Ketsueki. 2018;59(6):669-674. doi: 10.11406/rinketsu.59.669. Japanese.

PMID:
29973441
9.

Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database.

Fujioka I, Takaku T, Iriyama N, Tokuhira M, Kimura Y, Sato E, Ishikawa M, Nakazato T, Sugimoto KJ, Fujita H, Asou N, Kizaki M, Hatta Y, Komatsu N, Kawaguchi T.

Ann Hematol. 2018 Jun 26. doi: 10.1007/s00277-018-3412-8. [Epub ahead of print]

PMID:
29946911
10.

Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation.

Araki M, Yang Y, Imai M, Mizukami Y, Kihara Y, Sunami Y, Masubuchi N, Edahiro Y, Hironaka Y, Osaga S, Ohsaka A, Komatsu N.

Leukemia. 2018 Jun 26. doi: 10.1038/s41375-018-0181-2. [Epub ahead of print]

PMID:
29946189
11.

Efficacy of PCR-based open reading frame typing assay for outbreak investigation of metallo-╬▓-lactamase-producing Pseudomonas aeruginosa in hematology unit.

Nakamura A, Misawa S, Chonan M, Kawakami T, Horii T, Komatsu N, Ohsaka A.

J Infect Chemother. 2018 Jun 23. pii: S1341-321X(18)30168-5. doi: 10.1016/j.jiac.2018.06.002. [Epub ahead of print]

PMID:
29941274
12.

Retroperitoneal relapse in an older patient with multiple myeloma during pomalidomide and dexamethasone treatment.

Watanabe N, Kitahara H, Iwao N, Ohta Y, Koike M, Komatsu N.

Geriatr Gerontol Int. 2018 Jun;18(6):977-979. doi: 10.1111/ggi.13298. No abstract available.

PMID:
29924492
13.

A platform of BRET-FRET hybrid biosensors for optogenetics, chemical screening, and in vivo imaging.

Komatsu N, Terai K, Imanishi A, Kamioka Y, Sumiyama K, Jin T, Okada Y, Nagai T, Matsuda M.

Sci Rep. 2018 Jun 12;8(1):8984. doi: 10.1038/s41598-018-27174-x.

14.

Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors.

Nakazato T, Iriyama N, Tokuhira M, Ishikawa M, Sato E, Takaku T, Sugimoto KJ, Fujita H, Fujioka I, Kimura Y, Aisa Y, Iwanaga E, Asou N, Kizaki M, Hatta Y, Komatsu N, Kawaguchi T.

Med Oncol. 2018 May 30;35(7):99. doi: 10.1007/s12032-018-1159-7.

PMID:
29846829
15.

A Very Rare Case of Hypereosinophilic Syndrome Secondary to Natural Killer/T-Cell Lymphoma.

Yamamoto T, Kamijo A, Nakazawa T, Nakajima K, Kirito K, Komatsu N, Masuyama K.

Case Rep Otolaryngol. 2018 Mar 26;2018:5965029. doi: 10.1155/2018/5965029. eCollection 2018.

16.

Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations.

Takei H, Edahiro Y, Mano S, Masubuchi N, Mizukami Y, Imai M, Morishita S, Misawa K, Ochiai T, Tsuneda S, Endo H, Nakamura S, Eto K, Ohsaka A, Araki M, Komatsu N.

Br J Haematol. 2018 Jun;181(6):791-802. doi: 10.1111/bjh.15266. Epub 2018 May 9.

PMID:
29741776
17.

[Transfusion independence achieved with pomalidomide therapy in a patient with primary myelofibrosis].

Edahiro Y, Gotoh A, Inano T, Tsutsui M, Tsukune Y, Yasuda H, Komatsu N.

Rinsho Ketsueki. 2018;59(3):323-325. doi: 10.11406/rinketsu.59.323. Japanese.

PMID:
29618692
18.

Cryopreserved clumps of mesenchymal stem cell/extracellular matrix complexes retain osteogenic capacity and induce bone regeneration.

Motoike S, Kajiya M, Komatsu N, Takewaki M, Horikoshi S, Matsuda S, Ouhara K, Iwata T, Takeda K, Fujita T, Kurihara H.

Stem Cell Res Ther. 2018 Mar 21;9(1):73. doi: 10.1186/s13287-018-0826-0.

19.

Identification of CCL5/RANTES as a novel contraction-reducible myokine in mouse skeletal muscle.

Ishiuchi Y, Sato H, Komatsu N, Kawaguchi H, Matsuwaki T, Yamanouchi K, Nishihara M, Nedachi T.

Cytokine. 2018 Aug;108:17-23. doi: 10.1016/j.cyto.2018.03.012. Epub 2018 Mar 17.

PMID:
29558694
20.

Rapid and easy detection of low-level resistance to vancomycin in methicillin-resistant Staphylococcus aureus by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Asakura K, Azechi T, Sasano H, Matsui H, Hanaki H, Miyazaki M, Takata T, Sekine M, Takaku T, Ochiai T, Komatsu N, Shibayama K, Katayama Y, Yahara K.

PLoS One. 2018 Mar 9;13(3):e0194212. doi: 10.1371/journal.pone.0194212. eCollection 2018.

21.

Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.

Misawa K, Yasuda H, Araki M, Ochiai T, Morishita S, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.

Int J Hematol. 2018 Jun;107(6):673-680. doi: 10.1007/s12185-018-2421-7. Epub 2018 Feb 20.

PMID:
29464483
22.

Host defense against oral microbiota by bone-damaging T cells.

Tsukasaki M, Komatsu N, Nagashima K, Nitta T, Pluemsakunthai W, Shukunami C, Iwakura Y, Nakashima T, Okamoto K, Takayanagi H.

Nat Commun. 2018 Feb 16;9(1):701. doi: 10.1038/s41467-018-03147-6.

23.

Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase.

Tokuhira M, Kimura Y, Sugimoto K, Nakazato T, Ishikawa M, Fujioka I, Takaku T, Iriyama N, Sato E, Fujita H, Hatta Y, Komatsu N, Asou N, Kizaki M, Kawaguchi T.

Med Oncol. 2018 Feb 13;35(3):38. doi: 10.1007/s12032-018-1093-8.

PMID:
29442179
24.

The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.

Ochiai T, Yasuda H, Araki M, Misawa K, Morishita S, Nudejima M, Hironaka Y, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.

Eur J Haematol. 2018 Jun;100(6):544-549. doi: 10.1111/ejh.13041. Epub 2018 Apr 2.

PMID:
29405428
25.

Cationic Polyarginine Conjugated Mesoporous Bioactive Glass Nanoparticles with Polyglycerol Coating for Efficient DNA Delivery.

Li X, Zhao L, Liang Q, Liang Q, Ye J, Komatsu N, Zhang Q, Gao W, Xu M, Chen X.

J Biomed Nanotechnol. 2017 Mar;13(3):280-89.

PMID:
29381030
26.

Breakthrough Exophiala dermatitidis infection during prophylactic administration of micafungin during second umbilical cord blood transplantation after graft failure.

Watanabe N, Gotoh A, Shirane S, Hamano Y, Hirai Y, Shimizu M, Nakamura A, Matsumoto K, Morita K, Mori T, Ohsaka A, Komatsu N.

Transpl Infect Dis. 2018 Apr;20(2):e12833. doi: 10.1111/tid.12833. Epub 2018 Feb 12.

PMID:
29359870
27.

Therapeutic effects of tyrosine kinase inhibitors and subtypes of BCR-ABL1 transcripts in Japanese chronic myeloid leukemia patients with three-way chromosomal translocations.

Inokuchi K, Nakayama K, Tauchi T, Takaku T, Yokose N, Yamaguchi H, Kumagai T, Komatsu N, Ohyashiki K.

Leuk Res. 2018 Feb;65:74-79. doi: 10.1016/j.leukres.2018.01.005. Epub 2018 Jan 3.

PMID:
29310021
28.

Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms.

Sakurai H, Harada Y, Ogata Y, Kagiyama Y, Shingai N, Doki N, Ohashi K, Kitamura T, Komatsu N, Harada H.

Blood Adv. 2017 Jul 31;1(18):1382-1386. doi: 10.1182/bloodadvances.2016002725. eCollection 2017 Aug 8.

29.

Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms.

Ueda K, Ikeda K, Ikezoe T, Harada-Shirado K, Ogawa K, Hashimoto Y, Sano T, Ohkawara H, Kimura S, Shichishima-Nakamura A, Nakamura Y, Shikama Y, Mori T, Mason PJ, Bessler M, Morishita S, Komatsu N, Shide K, Shimoda K, Koide S, Aoyama K, Oshima M, Iwama A, Takeishi Y.

Blood Adv. 2017 Jun 14;1(15):1001-1015. doi: 10.1182/bloodadvances.2017004457. eCollection 2017 Jun 27.

30.

Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis.

Oritani K, Ohishi K, Okamoto S, Kirito K, Komatsu N, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Okada H, Amagasaki T, Wakase S, Shimozuma K, Akashi K.

Curr Med Res Opin. 2018 Mar;34(3):531-537. doi: 10.1080/03007995.2017.1415874. Epub 2018 Jan 4.

PMID:
29224367
31.

[Chronic myeloid leukemia complicated by pulmonary hypertension during dasatinib therapy: a single-center retrospective study].

Edahiro Y, Takaku T, Konishi H, Tsukune Y, Fujioka I, Takasu K, Gotoh A, Daida H, Komatsu N.

Rinsho Ketsueki. 2017;58(11):2213-2218. doi: 10.11406/rinketsu.58.2213. Japanese.

PMID:
29212971
32.

Monocyte-mediated chemotherapy drug delivery in glioblastoma.

Wang C, Li K, Li T, Chen Z, Wen Y, Liu X, Jia X, Zhang Y, Xu Y, Han M, Komatsu N, Zhao L, Chen X.

Nanomedicine (Lond). 2018 Jan;13(2):157-178. doi: 10.2217/nnm-2017-0266. Epub 2017 Nov 27.

PMID:
29173008
33.

Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan.

Tsukune Y, Sasaki M, Odajima T, Sunami K, Takei T, Moriuchi Y, Iino M, Isoda A, Nakaya A, Muta T, Miyake T, Miyazaki K, Shimizu T, Nakajima K, Igarashi A, Nagafuji K, Kurihara T, Aoyama T, Sugimori H, Komatsu N.

Blood Cancer J. 2017 Nov 23;7(12):631. doi: 10.1038/s41408-017-0002-2. No abstract available.

34.
35.

Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review.

Yasuda H, Tsutsui M, Ota Y, Tanaka M, Komatsu N.

Histopathology. 2018 Apr;72(5):862-866. doi: 10.1111/his.13433. Epub 2018 Jan 19.

PMID:
29143359
36.

Genetically Encoded Tools for Optical Dissection of the Mammalian Cell Cycle.

Sakaue-Sawano A, Yo M, Komatsu N, Hiratsuka T, Kogure T, Hoshida T, Goshima N, Matsuda M, Miyoshi H, Miyawaki A.

Mol Cell. 2017 Nov 2;68(3):626-640.e5. doi: 10.1016/j.molcel.2017.10.001. Epub 2017 Oct 26.

PMID:
29107535
37.

Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.

Li TF, Li K, Wang C, Liu X, Wen Y, Xu YH, Zhang Q, Zhao QY, Shao M, Li YZ, Han M, Komatsu N, Zhao L, Chen X.

J Control Release. 2017 Dec 28;268:128-146. doi: 10.1016/j.jconrel.2017.10.024. Epub 2017 Oct 16.

PMID:
29051064
38.

Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis.

Kirito K, Okamoto S, Ohishi K, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Oritani K, Akashi K, Okada H, Amagasaki T, Suzuki K, Yonezu T, Komatsu N.

Int J Hematol. 2018 Jan;107(1):92-97. doi: 10.1007/s12185-017-2332-z. Epub 2017 Oct 6.

PMID:
28986762
39.

Appropriate hinge position for prevention of unstable lateral hinge fracture in open wedge high tibial osteotomy.

Nakamura R, Komatsu N, Fujita K, Kuroda K, Takahashi M, Omi R, Katsuki Y, Tsuchiya H.

Bone Joint J. 2017 Oct;99-B(10):1313-1318. doi: 10.1302/0301-620X.99B10.BJJ-2017-0103.R1.

PMID:
28963152
40.

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

Kobayashi T, Nannya Y, Ichikawa M, Oritani K, Kanakura Y, Tomita A, Kiyoi H, Kobune M, Kato J, Kawabata H, Shindo M, Torimoto Y, Yonemura Y, Hanaoka N, Nakakuma H, Hasegawa D, Manabe A, Fujishima N, Fujii N, Tanimoto M, Morita Y, Matsuda A, Fujieda A, Katayama N, Ohashi H, Nagai H, Terada Y, Hino M, Sato K, Obara N, Chiba S, Usuki K, Ohta M, Imataki O, Uemura M, Takaku T, Komatsu N, Kitanaka A, Shimoda K, Watanabe K, Tohyama K, Takaori-Kondo A, Harigae H, Arai S, Miyazaki Y, Ozawa K, Kurokawa M; for National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Am J Hematol. 2017 Dec;92(12):1324-1332. doi: 10.1002/ajh.24905. Epub 2017 Sep 28.

PMID:
28891083
41.

Acute exacerbation of organizing pneumonia leading to sudden death in a patient with sarcoidosis-lymphoma syndrome.

Iizuka K, Ando J, Masuda A, Ochiai T, Tomomasa R, Yasuda H, Takaku T, Ota Y, Yao T, Gotoh A, Komatsu N.

Rinsho Ketsueki. 2017;58(8):927-932. doi: 10.11406/rinketsu.58.927. Japanese.

PMID:
28883276
42.

A case of Waldenstrom Macroglobulinemia in which intermittent one-day administration cycles of bendamustine were effective for alleviation of nausea and maintenance of remission.

Sekiguchi Y, Wakabayashi M, Takizawa H, Sugimoto K, Tomita S, Izumi H, Nakamura N, Sawada T, Ohta Y, Komatsu N, Noguchi M.

J Clin Exp Hematop. 2017 Oct 12;57(2):79-81. doi: 10.3960/jslrt.17022. Epub 2017 Sep 6. No abstract available.

43.

Successful eradication of Helicobacter pylori with a herbal medicine, goshuyuto (Wu Zhu Yu Tang), plus rabeprazole after failure of triplet therapy with vonoprazan: A report of three cases.

Nagata Y, Nagasaka K, Koyama S, Murase M, Saito M, Yazaki T, Komatsu N, Murase T, Uehara T, Taniuchi N.

J Dig Dis. 2017 Aug 28. doi: 10.1111/1751-2980.12537. [Epub ahead of print] No abstract available.

PMID:
28845910
44.

Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score.

Sato E, Iriyama N, Tokuhira M, Takaku T, Ishikawa M, Nakazato T, Sugimoto KJ, Fujita H, Fujioka I, Asou N, Komatsu N, Kizaki M, Hatta Y, Kawaguchi T.

Leuk Lymphoma. 2018 May;59(5):1105-1112. doi: 10.1080/10428194.2017.1365858. Epub 2017 Aug 25.

PMID:
28838287
45.

Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus.

Katayama Y, Azechi T, Miyazaki M, Takata T, Sekine M, Matsui H, Hanaki H, Yahara K, Sasano H, Asakura K, Takaku T, Ochiai T, Komatsu N, Chambers HF.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00452-17. doi: 10.1128/AAC.00452-17. Print 2017 Nov.

46.

Preparation of Robust Metal-Free Magnetic Nanoemulsions Encapsulating Low-Molecular-Weight Nitroxide Radicals and Hydrophobic Drugs Directed Toward MRI-Visible Targeted Delivery.

Nagura K, Takemoto Y, Moronaga S, Uchida Y, Shimono S, Shiino A, Tanigaki K, Amano T, Yoshino F, Noda Y, Koizumi S, Komatsu N, Kato T, Yamauchi J, Tamura R.

Chemistry. 2017 Nov 7;23(62):15713-15720. doi: 10.1002/chem.201702785. Epub 2017 Oct 12.

PMID:
28815766
47.

Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.

Okamoto K, Nakashima T, Shinohara M, Negishi-Koga T, Komatsu N, Terashima A, Sawa S, Nitta T, Takayanagi H.

Physiol Rev. 2017 Oct 1;97(4):1295-1349. doi: 10.1152/physrev.00036.2016. Review.

PMID:
28814613
48.

The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey.

Harrison CN, Koschmieder S, Foltz L, Guglielmelli P, Flindt T, Koehler M, Mathias J, Komatsu N, Boothroyd RN, Spierer A, Perez Ronco J, Taylor-Stokes G, Waller J, Mesa RA.

Ann Hematol. 2017 Oct;96(10):1653-1665. doi: 10.1007/s00277-017-3082-y. Epub 2017 Aug 5.

49.

Novel molecular mechanism of cellular transformation by a mutant molecular chaperone in myeloproliferative neoplasms.

Araki M, Komatsu N.

Cancer Sci. 2017 Oct;108(10):1907-1912. doi: 10.1111/cas.13327. Epub 2017 Aug 8. Review.

50.

The Amelioration of Myelofibrosis with Thrombocytopenia by a JAK1/2 Inhibitor, Ruxolitinib, in a Post-polycythemia Vera Myelofibrosis Patient with a JAK2 Exon 12 Mutation.

Ikeda K, Ueda K, Sano T, Ogawa K, Ikezoe T, Hashimoto Y, Morishita S, Komatsu N, Ohto H, Takeishi Y.

Intern Med. 2017;56(13):1705-1710. doi: 10.2169/internalmedicine.56.7871. Epub 2017 Jul 1.

Supplemental Content

Loading ...
Support Center